While breast cancer is a high-profile disease, receiving significant private and public research funding and focused awareness and prevention initiatives, patients with metastatic breast cancer face unique challenges. ACCC has identified these 6 effective principles for patient support.
(San Fernando Valley Business Journal) June 1, 2018 - The Food and Drug Administration has denied Amgen’s application for a biosimilar of Roche’s breast cancer drug Hercep
(Avalere) May 30, 2018 - New research from Avalere finds that 21% of cancer patients in Medicare Part B fee-fo
(Five Prime) May 30, 2018 - Five Prime Therapeutics, Inc.
Sign up to receive the latest on the ACCC Metastatic Breast Cancer Project